Get the Stockscreener App
11.42
0.95%
-0.11
After Hours:
11.42
Cogent Biosciences Inc stock is traded at $11.42, with a volume of 2.70M.
It is down -0.95% in the last 24 hours and up +59.05% over the past month.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
See More
Previous Close:
$11.53
Open:
$11.48
24h Volume:
2.70M
Relative Volume:
0.99
Market Cap:
$1.30B
Revenue:
-
Net Income/Loss:
$-242.30M
P/E Ratio:
-4.6048
EPS:
-2.48
Net Cash Flow:
$-192.10M
1W Performance:
-6.32%
1M Performance:
+59.05%
6M Performance:
+22.66%
1Y Performance:
+21.10%
1-Day Range:
$11.21
$11.63
1-Week Range:
$11.21
$12.41
52-Week Range:
$3.72
$12.97
Cogent Biosciences Inc Stock (COGT) Company Profile
Name
Cogent Biosciences Inc
Sector
Industry
Phone
617-945-5576
Address
275 WYMAN STREET, WALTHAM
Compare COGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
11.42 | 1.61B | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Dec-11-24 | Downgrade | Needham | Buy → Hold |
| Feb-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-08-24 | Initiated | Citigroup | Buy |
| Dec-11-23 | Downgrade | Wedbush | Outperform → Neutral |
| Dec-08-23 | Initiated | JP Morgan | Overweight |
| Apr-28-23 | Initiated | Robert W. Baird | Outperform |
| Mar-27-23 | Resumed | H.C. Wainwright | Buy |
| Dec-14-22 | Initiated | Needham | Buy |
| Jun-28-22 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | H.C. Wainwright | Buy |
| Jun-09-21 | Resumed | Jefferies | Buy |
| Dec-23-20 | Initiated | Piper Sandler | Overweight |
| Oct-14-20 | Initiated | Ladenburg Thalmann | Buy |
View All
Cogent Biosciences Inc Stock (COGT) Latest News
Is it the right time to buy Cogent Biosciences Inc. stockMarket Forecast Data Feed From AI Tools - jammulinksnews.com
What institutional investors are buying Cogent Biosciences Inc. stockRetirement Planning Insights For 2025 - jammulinksnews.com
What is the risk reward ratio of investing in Cogent Biosciences Inc. stockWealth Building Trend Scanner For 2025 - jammulinksnews.com
Published on: 2025-07-30 07:09:48 - metal.it
What makes Cogent Biosciences Inc. stock price move sharplyAccurate Buy Point for Momentum Stocks Detected - metal.it
Key External Factors That Drive Cogent Biosciences Inc. Stock Price MovementsRisk Controlled Picks With Real Returns Outlined - metal.it
Cogent Biosciences Inc. Shows Early Signs of Technical StrengthSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Cogent Biosciences Rated as a Buy at Citi on Robust Pipeline - MSN
How Efficient Is Cogent Biosciences Inc. at Controlling Operating CostsIntraday Trend Analysis for Fast Gains Released - metal.it
Why Cogent Biosciences Inc. stock attracts strong analyst attentionAlpha Driven Watchlist With Alerts Published - metal.it
Published on: 2025-07-28 05:03:28 - jammulinksnews.com
What is the dividend policy of Cogent Biosciences Inc. stockMaximize returns with data-driven strategies - jammulinksnews.com
What are Cogent Biosciences Inc. company’s key revenue driversMaximize returns with smart investment plans - jammulinksnews.com
How volatile is Cogent Biosciences Inc. stock compared to the marketAchieve breakthrough gains with smart trades - jammulinksnews.com
Should I hold or sell Cogent Biosciences Inc. stock in 2025Achieve consistent profits with proven methods - jammulinksnews.com
When is Cogent Biosciences Inc. stock expected to show significant growthOutstanding capital appreciation - jammulinksnews.com
Is Cogent Biosciences Inc. a Top Dividend Stock to Watch in 2025Momentum Swing Watchlist - metal.it
Published on: 2025-07-28 06:33:38 - jammulinksnews.com
What are the latest earnings results for Cogent Biosciences Inc.Triple-digit wealth increases - jammulinksnews.com
Intrinsic Value of Cogent Biosciences Inc. Stock: Is It Undervalued or OvervaluedFree Short-Term Stock Picks - metal.it
Is Cogent Biosciences Inc. stock overhyped or has real potentialTremendous portfolio expansion - jammulinksnews.com
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen - Insider Monkey
What analysts say about Cogent Biosciences Inc. stockPhenomenal capital appreciation - jammulinksnews.com
What drives Cogent Biosciences Inc. stock priceExceptional trading performance - Autocar Professional
2 Biotech and 2 Tech Stocks Insiders Are Scooping Up Now - 24/7 Wall St.
Is Cogent Biosciences Inc. a good long term investmentMarket-beating performance - jammulinksnews.com
Cogent Biosciences Inc. Stock Analysis and ForecastGame-changing returns - jammulinksnews.com
Citi Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
Cogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
3 Stocks With Sky-High Overbought Signals: QuantumScape, Opendoor, Cogent Flash RSI Red Flags - Benzinga
When (COGT) Moves Investors should Listen - news.stocktradersdaily.com
Cogent Biosciences Inc Stock (COGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):